InvestorsHub Logo
Followers 4
Posts 479
Boards Moderated 0
Alias Born 01/03/2015

Re: To infinity and beyond! post# 237675

Sunday, 08/19/2018 1:44:52 PM

Sunday, August 19, 2018 1:44:52 PM

Post# of 403025
Meant something to Dr B, who is a professional in his field. Meant enough to spend more money on it. My comments are based on facts from the company; your's is simply based on gut feel.

Company also commented...
Cellceutix is extremely proud of the Phase 2 Prurisol results. Simply put, the drug’s efficacy compares favorably with many current and various types of treatments for psoriasis (see the study linked to below), including apremilast or Otezla®, which is the leading oral FDA approved anti-psoriasis drug. It is interesting to do a side-by-side comparison between the two based on publicly available literature, and it could be argued that Prurisol performs on par with, if not better than, Otezla® at the identical stage of development
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News